Headlands Technologies LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1570271 CHICAGO, IL

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,251,050

+$4,218,640 QoQ

Shares Held

49,478

+170.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#531

of 2,266 holders

Holding Since

Jun 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Headlands Technologies LLC holds $15,176,459 across 5 Drug Manufacturers - General names. GILD ranks #1 (41.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	49,478	$6,251,050
2	ABBV	AbbVie Inc.	13,821	$3,477,916
3	LLY	ELI LILLY & Co	2,430	$2,914,615
4	MRK	Merck & Co., Inc.	10,997	$1,413,114
5	NVS	Novartis AG	7,145	$1,119,764

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,251,050	49,478	+170.2%	Shares	Sole	2026-08-13
2025-09-30	$2,032,410	18,310	-49.2%	Shares	Sole	2025-11-12
2025-03-31	$4,037,945	36,037	+75.8%	Shares	Sole	2025-05-09
2024-12-31	$1,893,400	20,498	+288.4%	Shares	Sole	2025-02-12
2024-09-30	$442,507	5,278	-78.1%	Shares	Sole	2024-11-12
2024-06-30	$1,650,001	24,049	+74.5%	Shares	Sole	2024-08-07
2024-03-31	$1,009,531	13,782	-56.5%	Shares	Sole	2024-05-07
2023-06-30	$2,440,729	31,669	—	Shares	Sole	2023-08-03
No filing history on record for this holder in this stock.